London, June 05, 2020 (GLOBE NEWSWIRE) -- Clinical trials have a vigorous supply chain management of the drugs considering the stringency of the regulations and the availability of the infrastructure for the efficient execution. The drug manufacturers and CROs have begun to outsource their logistics and material supply services to the third party for efficient functioning of the clinical trials. This has integrated the third-party vendors into the clinical trial development.
The global clinical trial materials and supplies market is poised to grow at a CAGR of 6% from 2019 to 2025 to reach $25.9 billion by 2025. The growth in this market is primarily expected to be driven by evolving treatment strategies, emerging clinical supplies markets in developing regions, growing advancements in clinical trial material supply chain process, rising investments and government funding for clinical trials and its supply chain management, and the increasing number of patent expiration. However, changing regulatory landscape and regulatory complexities in the countries is restricting the growth of the clinical trial materials and supplies market.
The global clinical trial materials and supplies market is mainly segmented by services, clinical type, phase outlook, medical specialty, and geography.
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5072
Based on services, the logistics and distribution segment commanded the largest share of the overall clinical trial materials and supplies market in 2019. The large share of this market is mainly attributed to the rising R&D cost, increased competition among small and mid-size manufacturers, and stringency over the prices of the medicine. Also, the increasing demand for biological and orphan drugs further promotes the growth of this market. However, the manufacturing and packaging segment is expected to grow with the fastest CAGR, due to the rising demand for specialty packaging and the increasing advancements like cold chain logistics.
Based on clinical trial type, the therapeutic and prevention segment commanded the largest share of the overall clinical trial materials and supplies market in 2019, mainly due to the increasing prevalence of various diseases, increased concentration of biopharmaceutical companies, and the rising investments in research and development by the drug manufacturers. The therapeutic and prevention segment is further sub-segmented into vaccines, drug discoveries and development, therapeutic devices, biosimilar, therapeutic assays, and therapeutic procedures. Vaccines accounted for the largest share of the overall market for therapeutic and prevention segment, due to the introduction of clinical trials for the infectious disease which contributes in the development of vaccines.
Based on medical specialty, oncology commanded the largest share of the overall clinical trial materials and supplies market in 2019, mainly due to the increasing number of clinical trials for the advancement of cancer treatments.
Quick Buy – Clinical Trial Materials and Supplies Market Research Report: https://www.meticulousresearch.com/buy_now.php?pformat=373&vformat=1106
Based on end user, the pharmaceuticals and biologics segment commanded largest share of the overall clinical trial materials and supplies market. The growth in this market is primarily attributed to the introduction of new clinical supply chain services. Moreover, majority of the companies developing biologics are start-ups or small to mid-size enterprises. However, the relative number of clinical trials in these companies is greater as compared to other end users such as CROs and medical device manufacturers, thereby demanding comparatively greater materials and supplies for clinical trials.
Geographically, North America was the largest market in 2019, followed by Europe, and Asia-Pacific. The large share of this region is primarily attributed to the increasing technological advancements, increasing cases of personalized medicines, increased complexity of material supply operations in clinical trials, growing investments by companies, and various government initiatives to increase the number of clinical trials. However, Asia Pacific region is slated to register the fastest growth during the forecast period, primarily due to increasing prevalence of various chronic diseases in the region, low cost of conducting a clinical trial as compared to western region, and increasing government initiatives to conduct clinical trials. Moreover, due to the stringent regulations for importing clinical supplies, clinical material and supply end-users are expected to strengthen their domestic presence in these countries.
Some of the key players operating in the global clinical trial materials and supplies market are Thermo Fisher Scientific Inc., Capsugel Inc., Parexel International Corporation, Eurofins Scientific Inc., Almac Group Ltd, Catalent Inc., Intertek Group plc, Mayne Pharma Group Ltd., Biocair International Ltd., Recipharm AB, Avomeen Analytical Services, and Bilcare Inc., among others.
Browse market research report: https://www.meticulousresearch.com/product/clinical-trial-materials-and-supplies-market-5072/
Scope of the Report:
Clinical Trial Materials and Supplies Market by Services
- Logistics and Distribution
- Manufacturing and Packaging
- IMPs and INDs
- Placebos
- Assays and Testkits
- Others
- Documentation
- Quantitative Clinical Development
- Clinical Operations
Clinical Trial Materials and Supplies Market by Clinical Trial Type
- Therapeutic and Prevention
- Vaccines
- Drug Discovery and Development
- Therapeutic Devices
- Biosimilars
- Therapeutic Assays
- Therapeutic Procedures
- Diagnostics
- Diagnostic Assay
- Diagnostic Devices
Clinical Trial Materials and Supplies Market by Phase Outlook
- Phase 3
- Phase 2
- Phase 1
Clinical Trial Materials and Supplies Market by Medical Specialty
- Oncology
- CNS and Mental Disorders
- Diabetes
- Cardiovascular Diseases
- Dermatology
- Respiratory Diseases
- Blood Disorders
- Gastrointestinal Diseases
- Infectious Diseases
- Ophthalmology
- Rare Diseases
Clinical Trial Materials and Supplies Market by End User
- Pharmaceuticals and Biologics
- Contract Research Organization
- Medical Device Companies
Clinical Trial Materials and Supplies Market by Geography
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- Japan
- China
- India
- Australia and New Zealand
- Rest of Asia-Pacific (RoAPAC)
- Latin America
- Middle East and Africa
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5072
Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to. assess the impact of COVID-19 on any industry here- https://www.meticulousresearch.com/custom-research.php
Related Reports:
Pharmaceutical Processing and Packaging Equipment Market by Mode of Drug Delivery (Oral, Parenteral, Topical), Secondary Packaging (Cartoning, Labeling), and End-Of-Line (Case Packaging, Palletizing, and Depalletizing) - Global Forecast to 2025
Pharmaceutical Storage and Material Handling Equipment Market by Type (Transport, Storage, Lifting Equipment, Stack Systems), Mode of Operation (Semi-Automatic, Automatic, Manual), Product Form (Solid, Liquid, Semi Solid), And Geography - Global Forecast to 2023
Biopharmaceutical Processing Equipment and Consumables Market by Product (Filtration, Chromatography, Columns, Bioreactor, Cell Culture, Service), Application (Commercial, Research), And End User (Pharmaceutical, Biotechnology, CDMO)- Global Forecast to 2023
Infectious Disease Diagnostics Market by Product and Solution (Consumables, System, Software and Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research) - Global Forecast to 2027
https://www.meticulousresearch.com/product/infectious-disease-diagnostics-market-4976/
About Meticulous Research®
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details.
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.
With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.